These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16101387)

  • 21. Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease.
    Lei Y; Renyuan Z
    Endocrinology; 2018 Dec; 159(12):3885-3894. PubMed ID: 30215697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
    Conway KA; Baxter EW; Felsenstein KM; Reitz AB
    Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Terminal Hypothesis for Alzheimer's Disease.
    Murray B; Sharma B; Belfort G
    ACS Chem Neurosci; 2017 Mar; 8(3):432-434. PubMed ID: 28186729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
    Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
    ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.
    Silva CS; Eira J; Ribeiro CA; Oliveira Â; Sousa MM; Cardoso I; Liz MA
    Neurobiol Aging; 2017 Nov; 59():10-14. PubMed ID: 28780366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abeta conformational change is central to Alzheimer's disease.
    Holtzman DM
    Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806
    [No Abstract]   [Full Text] [Related]  

  • 30. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
    Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
    J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a discordant helix on β-amyloid structure, aggregation ability and toxicity.
    Chen YC
    Eur Biophys J; 2017 Oct; 46(7):681-687. PubMed ID: 28687859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress and the Etiopathogenesis of Alzheimer's Disease and Depression.
    Sotiropoulos I; Silva JM; Gomes P; Sousa N; Almeida OFX
    Adv Exp Med Biol; 2019; 1184():241-257. PubMed ID: 32096043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualizing the growth of Alzheimer's A beta amyloid-like fibrils.
    Goldsbury C; Aebi U; Frey P
    Trends Mol Med; 2001 Dec; 7(12):582. PubMed ID: 11733223
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
    Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
    Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease.
    Hamaguchi T; Ono K; Yamada M
    Cell Mol Life Sci; 2006 Jul; 63(13):1538-52. PubMed ID: 16804637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyroglutamate-Aβ: role in the natural history of Alzheimer's disease.
    Gunn AP; Masters CL; Cherny RA
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1915-8. PubMed ID: 20833262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homodimerization Protects the Amyloid Precursor Protein C99 Fragment from Cleavage by γ-Secretase.
    Winkler E; Julius A; Steiner H; Langosch D
    Biochemistry; 2015 Oct; 54(40):6149-52. PubMed ID: 26403946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.